Den absolutte risiko for det kombinerede endepunkt var 3, 0% for den høje dosis af celecoxib, 2, 2% for den laveste dosis af celecoxib, og 0, 9 for placebo.
The absolute risk for the composite endpoint was 3.0% for the higher dose of celecoxib, 2.2% for the lower dose of celecoxib, and 0.9% for placebo.